Naturally Occurring Antibodies That Recognize Linear Epitopes in the Amino Terminus of the Hepatitis C Virus E2 Protein Confer Noninterfering, Additive Neutralization

被引:55
|
作者
Tarr, Alexander W. [1 ,2 ]
Urbanowicz, Richard A. [1 ,2 ]
Jayaraj, Dhanya [1 ,2 ]
Brown, Richard J. P. [1 ,2 ]
McKeating, Jane A. [3 ]
Irving, William L. [1 ,2 ]
Ball, Jonathan K. [1 ,2 ]
机构
[1] Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Nottingham NG7 2RD, England
[2] Univ Nottingham, Queens Med Ctr, Nottingham Digest Dis Ctr, Biomed Res Unit, Nottingham NG7 2RD, England
[3] Univ Birmingham, Inst Biomed Res, Birmingham, W Midlands, England
基金
英国医学研究理事会;
关键词
LIVER-TRANSPLANT RECIPIENTS; HUMAN MONOCLONAL-ANTIBODIES; SCAVENGER RECEPTOR BI; TO-CELL TRANSMISSION; ENVELOPE GLYCOPROTEIN; CD81; BINDING; CHRONIC INFECTION; VIRAL ENTRY; GENOTYPES; PARTICLES;
D O I
10.1128/JVI.06492-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Chronic hepatitis C virus (HCV) infection can persist even in the presence of a broadly neutralizing antibody response. Various mechanisms that underpin viral persistence have been proposed, and one of the most recently proposed mechanisms is the presence of interfering antibodies that negate neutralizing responses. Specifically, it has been proposed that antibodies targeting broadly neutralizing epitopes located within a region of E2 encompassing residues 412 to 423 can be inhibited by nonneutralizing antibodies binding to a less conserved region encompassing residues 434 to 446. To investigate this phenomenon, we characterized the neutralizing and inhibitory effects of human-derived affinity-purified immunoglobulin fractions and murine monoclonal antibodies and show that antibodies to both regions neutralize HCV pseudoparticle (HCVpp) and cell culture-infectious virus (HCVcc) infection albeit with different breadths and potencies. Epitope mapping revealed the presence of overlapping but distinct epitopes in both regions, which may explain the observed differences in neutralizing phenotypes. Crucially, we failed to demonstrate any inhibition between these two groups of antibodies, suggesting that interference by nonneutralizing antibodies, at least for the region encompassing residues 434 to 446, does not provide a mechanism for HCV persistence in chronically infected individuals.
引用
收藏
页码:2739 / 2749
页数:11
相关论文
共 50 条
  • [31] Antibodies to the E2 protein of GB virus C hepatitis G virus: Prevalence and risk factors in different populations in Italy
    Villari, P
    Ribera, G
    Nobile, CGA
    Torre, I
    Ricciardi, G
    INFECTION, 2001, 29 (01) : 17 - 23
  • [32] Identification of a domain containing B-cell epitopes in hepatitis C virus E2 glycoprotein by using mouse monoclonal antibodies
    Lee, JW
    Kim, KM
    Jung, SH
    Lee, KJ
    Choi, EC
    Sung, YC
    Kang, CY
    JOURNAL OF VIROLOGY, 1999, 73 (01) : 11 - 18
  • [33] Antibodies to the E2 Protein of GB Virus C/Hepatitis G Virus: Prevalence and Risk Factors in Different Populations in Italy
    P. Villari
    G. Ribera
    C.G.A. Nobile
    I. Torre
    G. Ricciardi
    Infection, 2001, 29 : 17 - 23
  • [34] Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein
    Owsianka, Ania M.
    Tarr, Alexander W.
    Keck, Zhen-Yong
    Li, Ta-Kai
    Witteveldt, Jeroen
    Adair, Richard
    Foung, Steven K. H.
    Ball, Jonathan K.
    Patel, Arvind H.
    JOURNAL OF GENERAL VIROLOGY, 2008, 89 : 653 - 659
  • [35] Structural properties of the ectodomain of hepatitis C virus E2 envelope protein
    Rodriguez-Rodriguez, Mar
    Tello, Daniel
    Yelamos, Belen
    Gomez-Gutierrez, Julian
    Pacheco, Beatriz
    Ortega, Sara
    Serrano, Alicia G.
    Peterson, Darrell L.
    Gavilanes, Francisco
    VIRUS RESEARCH, 2009, 139 (01) : 91 - 99
  • [36] The hepatitis C virus E2 protein is a novel kinase that controls endocytosis
    Buck, Martina
    HEPATOLOGY, 2006, 44 (04) : 225A - 225A
  • [37] Characterisation of bacterially expressed structural protein E2 of hepatitis C virus
    Yurkova, MS
    Patel, AH
    Fedorov, AN
    PROTEIN EXPRESSION AND PURIFICATION, 2004, 37 (01) : 119 - 125
  • [38] Hepatitis C virus core and E2 protein expression in transgenic mice
    Pasquinelli, C
    Shoenberger, JM
    Chung, J
    Chang, KM
    Guidotti, LG
    Selby, M
    Berger, K
    Lesniewski, R
    Houghton, M
    Chisari, FV
    HEPATOLOGY, 1997, 25 (03) : 719 - 727
  • [39] The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein
    Helle, Francois
    Goffard, Anne
    Morel, Virginie
    Duverlie, Gilles
    McKeating, Jane
    Keck, Zhen-Yong
    Foung, Steven
    Penin, Francois
    Dubuisson, Jean
    Voisset, Cecile
    JOURNAL OF VIROLOGY, 2007, 81 (15) : 8101 - 8111
  • [40] Significance of antibodies to the recombinant E2 protein of hepatitis G virus in hemodialysis patients.
    SchulteFrohlinde, E
    Reindl, W
    Schluter, V
    Schmolke, S
    Schatzle, G
    Scheri, J
    Classen, M
    HEPATOLOGY, 1997, 26 (04) : 781 - 781